retatrutide patent status (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Retatrutide FDA Approval Status 2026:

No estn pensadas para tratar afecciones crnicas ni para brindar atencin a largo plazo

Eli Lilly stock (LLY) popped by more than 5% on Wednesday after the Food and Drug Administration (FDA) approved the company's new weight-loss pill that Eli Lilly says can be taken "any time of day without food or water restrictions." The approval sets up a new phase of competition between Eli Lilly and its main competitor, Danish drugmaker Novo Nordisk (NVO), in the weight-loss drug space

Both medications are highly effective when prescribed correctly and managed with proper oversight

Research shows that artificially activating these receptors inhibits food intake, even when the stomach is empty

Most people with hypothyroidism due to Hashimotos thyroiditis will need lifelong treatment with thyroid hormone replacement (levothyroxine)

The fastest way to confirm is to check your plan formulary and your plans pharmacy benefit rulesand if youre denied, review the denial letter for whether its a criteria denial or a plan exclusion